University of Pittsburgh Medical Center UPMC — Pittsburgh, Pennsylvania

University of Pittsburgh Medical Center UPMC is a clinical research site located in Pittsburgh, Pennsylvania, United States 15213.

Crixeo Clinical Trials Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Pittsburgh Medical Center UPMC has participated in 5 clinical trials.

Therapeutic areas: PI3K Pathway Activated Tumors, Basal Cell Carcinoma, Chronic Graft-versus-host-disease.

Sponsors: Novartis Pharmaceuticals, Kadmon, a Sanofi Company, Replimune, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Pittsburgh

Browse all research sites in Pennsylvania · View every site in Pittsburgh

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Pittsburgh Medical Center UPMC?

University of Pittsburgh Medical Center UPMC has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Pittsburgh Medical Center UPMC conducted?

University of Pittsburgh Medical Center UPMC has 5 clinical trials on record. Their work covers PI3K Pathway Activated Tumors, Basal Cell Carcinoma, Chronic Graft-versus-host-disease.

Is University of Pittsburgh Medical Center UPMC accredited by Crixeo Clinical Trials?

University of Pittsburgh Medical Center UPMC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Pittsburgh Medical Center UPMC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.